Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Tofacitinib may help treat severe hair loss, but more research is needed.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Titagen® improves skin, hair, nail health, and reduces osteoarthritis symptoms safely.